Coronavirus India Highlights: Pharmaceutical companies Sanofi and GSK have received approval for the Phase 3 clinical study in India to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein Covid-19 vaccine candidate, news agency PTI reported.
The global, randomised, double-blind Phase 3 trial will include more than 35,000 volunteers aged 18 and older across countries like the US, Asia, Africa, and Latin America, Sanofi said in a statement.
As countries around the world rush to vaccinate their populations in the wake of more virulent variants, the global coronavirus death toll crossed the grim four million mark.
India reported 45,892 new coronavirus cases and 817 deaths in the last 24 hours, ending 8 am on Thursday. With this, the country’s overall caseload has risen to 3,07,09,557, while its death toll has climbed to 4,05,028. The number of active cases in the country has dropped to 4,60,704.
In other news, nearly a month after testing positive for Covid for a second time, Former Himachal Pradesh Chief Minister and Congress leader Virbhadra Singh passed away on Thursday, doctors told ANI. He was 87. As a mark of respect to the former chief minister, the state government has decided to observe three days of state mourning, from 8th July to 10th July.